Crossmark

Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury

Crossref DOI link: https://doi.org/10.1007/s13311-023-01421-0

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lindblad, Caroline https://orcid.org/0000-0003-4952-8597
Rostami, Elham

Helmy, Adel
Funding

Funding for this research was provided by:

Akademiska Sjukhuset

Medical Research Council (G0802251, R005036/1)

NIHR Cambridge Biomedical Research Centre

Uppsala University
License Information

Text and Data Mining valid from 2023-10-01

Text and Data Mining valid from 2023-10-01

Version of Record valid from 2023-10-23
More Information

This article is maintained by: Elsevier

Article Title: Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-023-01421-0

Content Type: article

Copyright: Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.